379 related articles for article (PubMed ID: 26494949)
21. Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study.
Endo K; Kakisaka K; Kuroda H; Miyasaka A; Takikawa Y; Matsumoto T
Sci Rep; 2023 Jan; 13(1):1648. PubMed ID: 36717617
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
Ebadi M; Montano-Loza AJ
Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
[TBL] [Abstract][Full Text] [Related]
23. Sarcopenia in Patients with Advanced Liver Disease.
Ponziani FR; Gasbarrini A
Curr Protein Pept Sci; 2018; 19(7):681-691. PubMed ID: 28462693
[TBL] [Abstract][Full Text] [Related]
24. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
Alvares-da-Silva MR; Reverbel da Silveira T
Nutrition; 2005 Feb; 21(2):113-7. PubMed ID: 15723736
[TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
[TBL] [Abstract][Full Text] [Related]
27. [The natural course of hepatitis B and hepatitis C virus infection].
Schwabe RF; Stremmel W
Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
[TBL] [Abstract][Full Text] [Related]
28. Nutritional issues in patients with obesity and cirrhosis.
Schiavo L; Busetto L; Cesaretti M; Zelber-Sagi S; Deutsch L; Iannelli A
World J Gastroenterol; 2018 Aug; 24(30):3330-3346. PubMed ID: 30122874
[TBL] [Abstract][Full Text] [Related]
29. Assessing the risk factors associated with sarcopenia in patients with liver cirrhosis: a case-control study.
Xiao L; Dai M; Zhao F; Shen Y; Kwan RYC; Salvador JT; Zhang L; Luo Y; Liu Q; Yang P
Sci Rep; 2023 Dec; 13(1):21845. PubMed ID: 38071233
[TBL] [Abstract][Full Text] [Related]
30. [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Yamada G
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):590-5. PubMed ID: 15359866
[No Abstract] [Full Text] [Related]
31. Natural history of chronic hepatitis C.
Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
[TBL] [Abstract][Full Text] [Related]
32. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
[TBL] [Abstract][Full Text] [Related]
33. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.
Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671926
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of hepatitis C virus-related cirrhosis].
Bronowicki JP
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
[No Abstract] [Full Text] [Related]
35. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
[TBL] [Abstract][Full Text] [Related]
36. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.
Montano-Loza AJ
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):173-86. PubMed ID: 23831908
[TBL] [Abstract][Full Text] [Related]
37. [Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].
Mesejo A; Juan M; Serrano A
Nutr Hosp; 2008 May; 23 Suppl 2():8-18. PubMed ID: 18714406
[TBL] [Abstract][Full Text] [Related]
38. Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C.
Vasel M; Rutz R; Bersch C; Feick P; Singer MV; Kirschfink M; Nakchbandi IA
Clin Immunol; 2014 Feb; 150(2):149-56. PubMed ID: 24412908
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
[TBL] [Abstract][Full Text] [Related]
40. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
J Hepatol; 2014 Jul; 61(1):22-7. PubMed ID: 24607623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
